Howard C Herrmann, MD, is a Professor of Medicine at the University of Pennsylvania School of Medicine and Director of Interventional Cardiology and the Cardiac Catheterization Laboratories at the Hospital of the University of Pennsylvania, Philadelphia. He has authored or co-authored more than 200 articles on numerous topics in interventional cardiology. His research focuses on the clinical investigation of new therapies for valvular and structural heart disease. He is Past President of the Pennsylvania Chapter of the American College of Cardiology (ACC) and serves on numerous national committees and Editorial Boards. Dr Herrmann earned his AB at Harvard College and his MD at Harvard Medical School, and completed his training at Massachusetts General Hospital.

Dr Yohei Ohno currently serves as a Director of Valve and Structural Heart Intervention Program at Tokai University Hospital, Isehara, Japan. He was a former clinical fellow at Ferrarotto Hospital, Catania, Italy with Prof Tamburino (ex-Course Director of PCR London Valves) where he trained in structural heart disease intervention including TAVI, MitraClip, LAAC, etc.

His main areas of interest are valvular heart disease intervention. He has been actively involved in many clinical trials involving new technologies and devices in the field of interventional cardiology. He also serves as one of the Course Directors of PCR Tokyo Valves.

Associate Professor Ron Dick is a Consultant Interventional Cardiologist located in Victoria. He has experience in all aspects of interventional cardiology and a special interest in the management of acute coronary syndrome including myocardial infarction, cardiogenic shock, and clinical research. A/Prof Ron Dick consults at Epworth Richmond, Frankston Private Hospital and St Francis House. He is also the Honorary Cardiologist at the Alfred Hospital and Bendigo Healthcare Group. Outside of his clinical work, he is the Chairman of the Cardiovascular Institute at Epworth Healthcare and was also the Past Chairman of the Medical Advisory Committee and Past Board of Management Member, both for Epworth Healthcare. After the completion of his Bachelor of Medicine, Bachelor of Surgery, Ron completed specialty training in cardiology followed by further training in interventional cardiology at the University of Michigan Medical Centre in the USA. A/Prof Ron Dick is a Fellow of the…

Dr Moyang Wang is an interventional cardiologist at Fuwai Hospital, Chinese Academy of Medical Sciences, one of China's most prestigious cardiovascular centers. Fuwai Hospital is a world-renowned institution dedicated to the prevention and treatment of cardiovascular and pulmonary diseases, and serves as the national referral center for complex cardiac cases in China. Dr Wang specializes in structural heart disease and transcatheter interventions, including transcatheter aortic valve replacement (TAVR). He brings a unique perspective on TAVR practice and outcomes from the Chinese healthcare setting, contributing to the growing body of evidence on structural heart disease management in Asia-Pacific populations.